ARTICLES BY LOUIS

• Geo-partnering With Global Suppliers

  7/24/2023

  Andrew Trigwell of Paradigm BioPharmaceuticals in Australia, deals in distances. He can teach you how long-distance outsourcing can work, and how to meet the challenges of a global supply chain.

• A QR Code For Finding The Right CDMO

  7/19/2023

  Is it getting more difficult to select the best CDMO? Too many choices with similar pitches? If only there were QR codes to scan for help in locating the right CDMOs. Let me explain.

• Is Your “Preferred Provider List” Legacy-Heavy?

  7/17/2023

  Doesn’t an approved/preferred service-provider list facilitate partner selection? Ronald Lewis thinks it depends. "As you evolve as a company,” he says, “it probably makes sense in most cases to trim these down and streamline.”

• Is Your CDMO Relevant? How To Find Out

  7/12/2023

  Ron Lewis, Sr. of MEI Pharma, harkens back two decades to outsourcing gems he’s mined over his career. A most vital question: "Has the CDMO been in the industry for years, do they seem stale, are they still relevant?”  

• Does Diversity At CDMOs Matter?

  7/5/2023

  “That's a really interesting question,” replies Sara McCutchan, during a conversation we had a few months ago. “I've actually seen very diverse representation at our CDMOs, which is great."

• The FDA's Sway On AI

  6/29/2023

  The FDA’s CDER published a paper titled “Artificial Intelligence in Drug Manufacturing" to facilitate input from outside the agency. Here's some of that input from Chief Editor Louis Garguilo.

• 3 Updated Fundamentals Of Outsourcing

  6/26/2023

  Here are three newly updated key factors for increasing your chances of personal, programmatic, and organizational success, as you pursue the activities known collectively as drug development and manufacturing outsourcing.

• Economical Outsourcing: Should I Stay Or Should I Go?

  6/19/2023

  I doubt The Clash contemplated drug development and manufacturing when they penned their classic song, “Should I Stay of Should I Go.” But they could have. The question of staying internal with your programs or going to service providers - around the world - can be difficult to answer.

• If The Economy Squeezes CDMOs, They Squeeze You?

  6/15/2023

  A tale of outsourcing woe documents challenges biotechs face during economic-challenging cycles. The story serves as a cogent reminder long-duration strategies get crunched by inflation, and biotech is a long-duration strategy.

• CDMOs Shine When Inflation Clouds Innovation

  6/12/2023

  A report says rather than those regularly tagged for any deceleration of innovation (e.g., poor corporate culture; diminishing funding, revenues and/or profits), today CEOs say inflation specifically is the leading culprit. CDMOs to the rescue.